Log in to save to my catalogue

Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes

Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5a5b2bbb2f2147bf8cd9959dcec76d0d

Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes

About this item

Full title

Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2019-10, Vol.10 (1), p.4523-15, Article 4523

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Arctigenin (ATG) is a major component of
Fructus Arctii
, a traditional herbal remedy that reduced proteinuria in diabetic patients. However, whether ATG specifically provides renoprotection in DKD is not known. Here we report that ATG administration is sufficient to attenuate proteinuria and podocyte injury in mouse models of diabetes. Trans...

Alternative Titles

Full title

Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5a5b2bbb2f2147bf8cd9959dcec76d0d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5a5b2bbb2f2147bf8cd9959dcec76d0d

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-019-12433-w

How to access this item